Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

NCT: NCT06386497 · RECRUITING

NCT IDNCT06386497
StatusRECRUITING
Start Date2024-01-11
Completion2027-12-31

Brief Summary

This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.

Frequently Asked Questions

What is Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease?

Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease is a clinical trial registered under NCT06386497. Current status: RECRUITING.

What is the status of NCT06386497?

The current status of NCT06386497 (Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease) is: RECRUITING.

When did Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease start?

Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease started on 2024-01-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑